WASHINGTON — The Coalition for a Prosperous America (CPA) today released a new study of the CPA Reshoring Index (CRI) showing domestic manufacturers’ market share in the domestic U.S. manufactured goods market. The CRI rose slightly from 69.4 in 2019 to 69.6 in 2020, indicating domestic producers met only 69.6% of total U.S. demand for…
When President Biden laid out his vision for the U.S. economy before Congress on April 28th, he emphasized that rebuilding the U.S. economy should focus on “jobs, jobs, jobs.” The federal government should give preference to U.S.-made products as much as possible. To hammer home the point, Biden added: “there is simply no reason why…
McKinsey has turned the corner on the Asia-centric model of globalization. It’s a “now-or-never” moment for US manufacturing. Here’s where CPA sees eye-to-eye.
How do we bring back generic drug manufacturing to the United States in order to be less reliant on India, China? A National Academies of Science conference brings in some experts to try and answer that, including the chair of CPA Healthcare Committee.
A Senate hearing today looked back at our early response to the pandemic. A year later, what went right, what went wrong, and how to re-shore pharma now.
If the White House believes we are facing a climate emergency, then the Biden administration will have to work overtime explaining why outsourcing pollution to China is a good idea. We can produce those goods here, with a smaller carbon footprint.
Reshoring & Re-establishing Supply Chains — Doing so brings jobs, assets, and resources back to the U.S.. Harry Moser, founder and president, of the Reshoring Initiative talks with Melissa in episode 6 of Coalition Conversations. Want to learn more on the Reshoring Initiative and the programs Harry has worked on? Visit the following links: Reshoring Initiative…